NICOLE MUSCARI: Open Payments
NPI 1154843043 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 108 payments from 16 companies in 2025. Trend: 2023 $1,914 · 2024 $1,498 · 2025 $1,839
Food & beverage: $1,839
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $298 |
| E.R. Squibb & Sons, L.L.C. | 24 | $277 |
| Alkermes, Inc. | 13 | $252 |
| Otsuka America Pharmaceutical, Inc. | 15 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $195 |
| ABBVIE INC. | 12 | $137 |
| Neurocrine BioSciences, Inc. | 6 | $104 |
| Supernus Pharmaceuticals, Inc. | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
Products named: Auvelity, COBENFY, CAPLYTA, ARISTADA, REXULTI, VRAYLAR, INGREZZA, LYBALVI.
Industry payments across OH — which companies pay providers there.
